Page last updated: 2024-11-01

nomifensine and Autosomal Dominant Juvenile Parkinson Disease

nomifensine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research Excerpts

ExcerptRelevanceReference
" The nicotinic agonists were given acutely and repeatedly either alone or in combination with a dopamine uptake inhibitor, nomifensine."1.33Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats. ( Ahtee, L; Janhunen, S; Tuominen, RK, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janhunen, S1
Tuominen, RK1
Ahtee, L1

Other Studies

1 other study available for nomifensine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
    Neuroscience letters, 2005, Jun-24, Volume: 381, Issue:3

    Topics: Adrenergic Agents; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Uptake Inhibito

2005